FDA Rejection Of MDMA Could Fuel Black Market Demand, Warns CEO Of Women's Psychedelic Platform SetSet
Posted
Franca Quarneti (via Benzinga)
The FDA rejected MDMA-assisted therapy for PTSD. SetSet's April Pride calls for harm-reduction education and regulatory change.
read more
Continue reading at Benzinga »
Keywords
April Pride,
Cannabis,
FDA,
MDMA,
News,
Psychedelics,
SetSet,
Legal,
Exclusives,
Markets,
Interview,
News,
Cannabis,
Psychedelics,
Legal,
Exclusives,
Markets,
Interview,
Benzinga
